The BBBA is a disastrous and wasteful bill that will raise costs further for all Americans and increase government control.
Build Back Better Act Will Destroy Vibrant U.S. Pharmaceutical Industry
CAGW’s latest report “Price Controls on Pharmaceuticals Are Bad Medicine,” analyzes destructive policies in the BBBA.
Three Reforms States Should Consider After the COVID-19 Pandemic
States should reform how they raise revenue, plan better for the future, and relax workforce regulations.
The Republic is Safe, For Now
Congress has been on recess for a week, so the nation is safe from more prolific spending – for now.
Congress Should Listen to Voters and Reject Drug Price Controls
A message was sent by voters in Virginia, New Jersey, and New York last night. Is Congress listening?
Price Controls Must Not Be Included in Reconciliation
The Biden administration and congressional leaders aim to implement price controls on healthcare.
Tobacco Harm Reduction Products Help Smokers Quit
It is discouraging to see governments around the world restrict access to THR products.
States Must Use Caution When Spending ARPA Funds to Avoid Waste
State leaders will have to allocate ARPA funds with caution to avoid supporting wasteful and unsustainable projects.
WHO Reopens Investigation into Origins of COVID-19 Virus
The World Health Organization reopens an investigation on origin of the corona virus; will China cooperate? What can Congress do?
President Biden is Raising Taxes for Those Earning Less Than 400K
Excise taxes on tobacco harm reduction products are irrational; it hurts both financially and those trying to quit smoking.